SSX2IP Antibody / Synovial sarcoma X breakpoint protein 2 interacting protein, 100 ul

SSX2IP antibody detects synovial sarcoma X breakpoint protein 2 interacting protein, a centrosomal protein involved in cell division and spindle organization. SSX2IP contributes to centrosome maturation and stability, facilitating accurate chromosome segregation. It has also been implicated in ciliogenesis, reflecting its role in microtubule-based processes beyond mitosis.

Research using SSX2IP antibody has linked the protein to cancer progression. Altered expression of SSX2IP has been observed in hematologic malignancies and solid tumors, where it may affect proliferation and genomic stability. SSX2IP also plays a role in cell adhesion and migration, adding to its importance in tumor biology. In developmental contexts, its regulation of ciliogenesis connects it to congenital disorders tied to defective ciliary signaling.

Antibodies against SSX2IP are applied in western blot, immunofluorescence, and immunohistochemistry. These reagents enable investigation of centrosome integrity, mitotic processes, and ciliary dynamics. Clone validation ensures reproducible results across research applications.

NSJ Bioreagents supplies this SSX2IP antibody for studies in cell cycle regulation, cancer biology, and ciliary function. Alternate names include synovial sarcoma X breakpoint protein 2 interacting protein antibody, AF-15q14 antibody, and centrosomal protein SSX2IP antibody.